4//SEC Filing
Gamelin Erick 4
Accession 0000905148-23-001474
CIK 0001781174other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 7:41 PM ET
Size
4.4 KB
Accession
0000905148-23-001474
Insider Transaction Report
Form 4
Gamelin Erick
Chief Development Officer
Transactions
- Tax Payment
Common Stock
2023-11-14$5.08/sh−1,395$7,087→ 18,635 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.
Documents
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeother
Related Parties
1- filerCIK 0001950551
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 7:41 PM ET
- Size
- 4.4 KB